CD274 and neoplasm: Furthermore, we previously confirmed that suppression of sEV PD-L1 secretion through the inhibition of tumor-derived sEV secretion by the ETA antagonists sulfisoxazole and macitentan caused the activation of immune cells, thereby exhibiting anti-cancer effects [16,17,18].